Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ryanodine-sensitive calcium-release channel activity	RYR1 RYR3	1.23e-04	4	91	2	GO:0005219
GeneOntologyMolecularFunction	calcium-induced calcium release activity	RYR1 RYR3	3.04e-04	6	91	2	GO:0048763
GeneOntologyMolecularFunction	calcium channel activity	TRPM5 CATSPER2 TRPM1 RYR1 RYR3	3.10e-04	129	91	5	GO:0005262
GeneOntologyMolecularFunction	ligand-gated calcium channel activity	TRPM5 RYR1 RYR3	3.75e-04	31	91	3	GO:0099604
GeneOntologyMolecularFunction	calcium ion transmembrane transporter activity	TRPM5 CATSPER2 TRPM1 RYR1 RYR3	6.38e-04	151	91	5	GO:0015085
GeneOntologyBiologicalProcess	neuroblast division	NUMBL AKNA FGFR2	4.04e-05	16	88	3	GO:0055057
GeneOntologyBiologicalProcess	microtubule-based protein transport	MYO5A CAMSAP3 CEP131	4.89e-05	17	88	3	GO:0099118
GeneOntologyBiologicalProcess	protein transport along microtubule	MYO5A CAMSAP3 CEP131	4.89e-05	17	88	3	GO:0098840
GeneOntologyBiologicalProcess	neuroblast division in subventricular zone	NUMBL AKNA	5.38e-05	3	88	2	GO:0021849
Domain	Ryanrecept_TM4-6	RYR1 RYR3	7.18e-05	3	92	2	IPR009460
Domain	RyR	RYR1 RYR3	7.18e-05	3	92	2	PF02026
Domain	Ryanodine_rcpt	RYR1 RYR3	7.18e-05	3	92	2	IPR003032
Domain	RR_TM4-6	RYR1 RYR3	7.18e-05	3	92	2	PF06459
Domain	Ryan_recept	RYR1 RYR3	7.18e-05	3	92	2	IPR013333
Domain	Ion_trans_dom	TRPM5 CATSPER2 TRPM1 RYR1 RYR3	2.50e-04	114	92	5	IPR005821
Domain	Ion_trans	TRPM5 CATSPER2 TRPM1 RYR1 RYR3	2.50e-04	114	92	5	PF00520
Domain	RIH_assoc	RYR1 RYR3	3.55e-04	6	92	2	PF08454
Domain	RIH_assoc-dom	RYR1 RYR3	3.55e-04	6	92	2	IPR013662
Domain	RIH_dom	RYR1 RYR3	3.55e-04	6	92	2	IPR000699
Domain	Ins145_P3_rcpt	RYR1 RYR3	3.55e-04	6	92	2	IPR014821
Domain	Ryanodine_recept-rel	RYR1 RYR3	3.55e-04	6	92	2	IPR015925
Domain	-	RYR1 RYR3	3.55e-04	6	92	2	1.25.10.30
Domain	RYDR_ITPR	RYR1 RYR3	3.55e-04	6	92	2	PF01365
Domain	Ins145_P3_rec	RYR1 RYR3	3.55e-04	6	92	2	PF08709
Domain	Shisa	SHISA9 SHISA3	8.45e-04	9	92	2	PF13908
Domain	Shisa	SHISA9 SHISA3	8.45e-04	9	92	2	IPR026910
Domain	MIR	RYR1 RYR3	1.05e-03	10	92	2	PS50919
Domain	MIR	RYR1 RYR3	1.05e-03	10	92	2	PF02815
Domain	MIR	RYR1 RYR3	1.05e-03	10	92	2	SM00472
Domain	MIR_motif	RYR1 RYR3	1.05e-03	10	92	2	IPR016093
Domain	Sulfatase_CS	ARSJ ARSI	2.75e-03	16	92	2	IPR024607
Domain	SULFATASE_1	ARSJ ARSI	3.11e-03	17	92	2	PS00523
Domain	SULFATASE_2	ARSJ ARSI	3.11e-03	17	92	2	PS00149
Domain	Sulfatase	ARSJ ARSI	3.49e-03	18	92	2	PF00884
Domain	Integrin_alpha-2	ITGA11 ITGA7	3.49e-03	18	92	2	IPR013649
Domain	Integrin_alpha2	ITGA11 ITGA7	3.49e-03	18	92	2	PF08441
Domain	Integrin_alpha	ITGA11 ITGA7	3.49e-03	18	92	2	IPR000413
Domain	Sulfatase_N	ARSJ ARSI	3.49e-03	18	92	2	IPR000917
Domain	INTEGRIN_ALPHA	ITGA11 ITGA7	3.49e-03	18	92	2	PS00242
Domain	Int_alpha_beta-p	ITGA11 ITGA7	3.89e-03	19	92	2	IPR013519
Domain	Int_alpha	ITGA11 ITGA7	3.89e-03	19	92	2	SM00191
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PPP1R26 ARSJ KANSL1 RPAP1 ESYT1 NLRX1 TMC6 AKNA SDF4 TSC2 CEP131 FGFR2 PC RYR1 FANCA	2.06e-07	1105	92	15	35748872
Pubmed	Principal mutation hotspot for central core disease and related myopathies in the C-terminal transmembrane region of the RYR1 gene.	RYR1 RYR3	6.92e-06	2	92	2	12565913
Pubmed	Contractile impairment and structural alterations of skeletal muscles from knockout mice lacking type 1 and type 3 ryanodine receptors.	RYR1 RYR3	6.92e-06	2	92	2	9489997
Pubmed	Functional and morphological features of skeletal muscle from mutant mice lacking both type 1 and type 3 ryanodine receptors.	RYR1 RYR3	6.92e-06	2	92	2	9192302
Pubmed	Elevated Thyroid Autoantibodies Aggravate Stroke Severity in Euthyroidism with Acute Ischemic Stroke.	TPO TG	6.92e-06	2	92	2	35256895
Pubmed	The block of ryanodine receptors selectively inhibits fetal myoblast differentiation.	RYR1 RYR3	6.92e-06	2	92	2	12640042
Pubmed	Myosin Va and Endoplasmic Reticulum Calcium Channel Complex Regulates Membrane Export during Axon Guidance.	MYO5A RYR3	6.92e-06	2	92	2	27134178
Pubmed	The prevalence of iodine deficiency, serum thyroglobulin, anti-thyroglobulin and thyroid peroxidase antibody levels in the urban areas of Kayseri, Central Anatolia.	TPO TG	6.92e-06	2	92	2	19194833
Pubmed	Isolation and partial cloning of ryanodine-sensitive Ca2+ release channel protein isoforms from human myometrial smooth muscle.	RYR1 RYR3	6.92e-06	2	92	2	7556644
Pubmed	Lack of a role for cross-reacting anti-thyroid antibodies in chronic idiopathic urticaria.	TPO TG	6.92e-06	2	92	2	20182447
Pubmed	Possible involvement of ryanodine receptor-mediated intracellular calcium release in the effect of corticotropin-releasing factor on adrenocorticotropin secretion.	RYR1 RYR3	6.92e-06	2	92	2	14592949
Pubmed	Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.	LRP1 ADAM10	6.92e-06	2	92	2	27503326
Pubmed	Anti-Helicobacter Pylori, anti-thyroid peroxidase, anti-thyroglobulin and anti-gastric parietal cells antibodies in Czech population.	TPO TG	6.92e-06	2	92	2	18271683
Pubmed	Ryanodine receptors in muscarinic receptor-mediated bronchoconstriction.	RYR1 RYR3	6.92e-06	2	92	2	15894801
Pubmed	Morphological abnormalities of adrenal gland and hypertrophy of liver in mutant mice lacking ryanodine receptors.	RYR1 RYR3	6.92e-06	2	92	2	9799464
Pubmed	Mutations in the genes for thyroglobulin and thyroid peroxidase cause thyroid dyshormonogenesis and autosomal-recessive intellectual disability.	TPO TG	6.92e-06	2	92	2	27305979
Pubmed	Expression of the Na+/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes.	TPO TG	6.92e-06	2	92	2	10487692
Pubmed	Effect of calmodulin on Ca2+-induced Ca2+ release of skeletal muscle from mutant mice expressing either ryanodine receptor type 1 or type 3.	RYR1 RYR3	6.92e-06	2	92	2	9817784
Pubmed	Expression and distribution of trophoblast glycoprotein in the mouse retina.	TRPM1 TPBG	6.92e-06	2	92	2	31891182
Pubmed	Increased Prevalence of TG and TPO Mutations in Sudanese Children With Congenital Hypothyroidism.	TPO TG	6.92e-06	2	92	2	31867598
Pubmed	Antibodies to thyroid peroxidase arise spontaneously with age in NOD.H-2h4 mice and appear after thyroglobulin antibodies.	TPO TG	6.92e-06	2	92	2	20573721
Pubmed	Expression and functional activity of ryanodine receptors (RyRs) during skeletal muscle development.	RYR1 RYR3	6.92e-06	2	92	2	17118445
Pubmed	Evidence of a combined cytotoxic thyroglobulin and thyroperoxidase epitope-specific cellular immunity in Hashimoto's thyroiditis.	TPO TG	6.92e-06	2	92	2	22259066
Pubmed	RyR3 amplifies RyR1-mediated Ca(2+)-induced Ca(2+) release in neonatal mammalian skeletal muscle.	RYR1 RYR3	6.92e-06	2	92	2	11500519
Pubmed	Increased TIMP-3 expression alters the cellular secretome through dual inhibition of the metalloprotease ADAM10 and ligand-binding of the LRP-1 receptor.	LRP1 ADAM10	2.07e-05	3	92	2	30279425
Pubmed	Structural Basis of Formation of the Microtubule Minus-End-Regulating CAMSAP-Katanin Complex.	KATNB1 CAMSAP3	2.07e-05	3	92	2	29395789
Pubmed	Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: an antisense study.	RYR1 RYR3	2.07e-05	3	92	2	18403125
Pubmed	Characterization and mapping of the 12 kDa FK506-binding protein (FKBP12)-binding site on different isoforms of the ryanodine receptor and of the inositol 1,4,5-trisphosphate receptor.	RYR1 RYR3	2.07e-05	3	92	2	11171121
Pubmed	Type I interferons modulate the expression of thyroid peroxidase, sodium/iodide symporter, and thyroglobulin genes in primary human thyrocyte cultures.	TPO TG	2.07e-05	3	92	2	15562032
Pubmed	Inverse Data-Driven Modeling and Multiomics Analysis Reveals Phgdh as a Metabolic Checkpoint of Macrophage Polarization and Proliferation.	TSC2 PHGDH	2.07e-05	3	92	2	32023468
Pubmed	Differential alterations in expressions of ryanodine receptor subtypes in cerebellar cortical neurons of an ataxic mutant, rolling mouse Nagoya.	RYR1 RYR3	2.07e-05	3	92	2	18313230
Pubmed	TSH stimulation of human thyroglobulin and thyroid peroxidase gene transcription is partially dependent on internalization.	TPO TG	2.07e-05	3	92	2	34896620
Pubmed	Heterogeneous gene expression and functional activity of ryanodine receptors in resistance and conduit pulmonary as well as mesenteric artery smooth muscle cells.	RYR1 RYR3	2.07e-05	3	92	2	18434746
Pubmed	SPRY domains in ryanodine receptors (Ca(2+)-release channels).	RYR1 RYR3	2.07e-05	3	92	2	9204703
Pubmed	The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues.	RYR1 RYR3	2.07e-05	3	92	2	7876312
Pubmed	Ryanodine receptors are expressed in epidermal keratinocytes and associated with keratinocyte differentiation and epidermal permeability barrier homeostasis.	RYR1 RYR3	2.07e-05	3	92	2	21881589
Pubmed	Transitional B cells commit to marginal zone B cell fate by Taok3-mediated surface expression of ADAM10.	TAOK3 ADAM10	2.07e-05	3	92	2	28068307
Pubmed	Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors).	RYR1 RYR3	2.07e-05	3	92	2	12213830
Pubmed	Expression of the ryanodine receptor type 3 calcium release channel during development and differentiation of mammalian skeletal muscle cells.	RYR1 RYR3	2.07e-05	3	92	2	9242641
Pubmed	Genotypes and phenotypes of congenital goitre and hypothyroidism caused by mutations in dual oxidase 2 genes.	TPO TG	2.07e-05	3	92	2	24735383
Pubmed	Bidirectional coupling between ryanodine receptors and Ca2+ release-activated Ca2+ (CRAC) channel machinery sustains store-operated Ca2+ entry in human T lymphocytes.	RYR1 RYR3	2.07e-05	3	92	2	22948152
Pubmed	Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain.	RYR1 RYR3	2.07e-05	3	92	2	10788707
Pubmed	Molecular cloning and initial characterization of three novel human sulfatases.	ARSJ ARSI	2.07e-05	3	92	2	16500042
Pubmed	Relationship of clinical features and laboratory parameters to thyroid echogenicity measured by standardized grey scale ultrasonography in patients with Hashimoto's thyroiditis.	TPO TG	2.07e-05	3	92	2	12709678
Pubmed	Calcineurin upregulates local Ca(2+) signaling through ryanodine receptor-1 in airway smooth muscle cells.	RYR1 RYR3	2.07e-05	3	92	2	25239916
Pubmed	Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor.	RYR1 RYR3	2.07e-05	3	92	2	7621815
Pubmed	A gene-specific cerebral types 1, 2, and 3 RyR protein knockdown induces an antidepressant-like effect in mice.	RYR1 RYR3	2.07e-05	3	92	2	18643873
Pubmed	Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2).	RYR1 RYR3	2.07e-05	3	92	2	11159936
Pubmed	Homology between TSH-R/Tg/TPO and Hashimoto's encephalopathy autoantigens.	TPO TG	2.07e-05	3	92	2	31585887
Pubmed	Elevated blood Hsp60, its structural similarities and cross-reactivity with thyroid molecules, and its presence on the plasma membrane of oncocytes point to the chaperonin as an immunopathogenic factor in Hashimoto's thyroiditis.	TPO TG	2.07e-05	3	92	2	24057177
Pubmed	Comprehensive Screening of Eight Known Causative Genes in Congenital Hypothyroidism With Gland-in-Situ.	TPO TG	2.07e-05	3	92	2	27525530
Pubmed	Molecular identification of the ryanodine receptor pore-forming segment.	RYR1 RYR3	2.07e-05	3	92	2	10473538
Pubmed	Biological variation of thyroid autoantibodies and thyroglobulin.	TPO TG	2.07e-05	3	92	2	17902201
Pubmed	Chromosomal localization of murine ryanodine receptor genes RYR1, RYR2, and RYR3 by in situ hybridization.	RYR1 RYR3	2.07e-05	3	92	2	7959768
Pubmed	The organization of proteins in the human red blood cell membrane. A review.	RYR1 RYR3	2.07e-05	3	92	2	4600883
Pubmed	Regulation of mouse egg activation: presence of ryanodine receptors and effects of microinjected ryanodine and cyclic ADP ribose on uninseminated and inseminated eggs.	RYR1 RYR3	2.07e-05	3	92	2	7635066
Pubmed	The Interleukin-2-mTORc1 Kinase Axis Defines the Signaling, Differentiation, and Metabolism of T Helper 1 and Follicular B Helper T Cells.	KATNB1 FAM83D DGKH CCNA2 AGAP2 FANCA	3.23e-05	227	92	6	26410627
Pubmed	Characterization of the binding sites for the interactions between FKBP12 and intracellular calcium release channels.	RYR1 RYR3	4.14e-05	4	92	2	22100703
Pubmed	A glutathione deficit alters dopamine modulation of L-type calcium channels via D2 and ryanodine receptors in neurons.	RYR1 RYR3	4.14e-05	4	92	2	18206662
Pubmed	A hereditary model of slowly progressive polycystic kidney disease in the mouse.	NPHP3 MYO5A	4.14e-05	4	92	2	1883968
Pubmed	IKKbeta suppression of TSC1 function links the mTOR pathway with insulin resistance.	TSC2 IKBKB	4.14e-05	4	92	2	18949383
Pubmed	Ryanodine receptor calcium release channels: lessons from structure-function studies.	RYR1 RYR3	4.14e-05	4	92	2	23413940
Pubmed	Requirement for the ryanodine receptor type 3 for efficient contraction in neonatal skeletal muscles.	RYR1 RYR3	4.14e-05	4	92	2	9384575
Pubmed	Partial cloning and differential expression of ryanodine receptor/calcium-release channel genes in human tissues including the hippocampus and cerebellum.	RYR1 RYR3	4.14e-05	4	92	2	9607712
Pubmed	An autophagy-related model of 4 key genes for predicting prognosis of patients with laryngeal cancer.	TSC2 IKBKB	4.14e-05	4	92	2	32791689
Pubmed	Linkage analysis of two murine polycystic kidney disease genes, pcy and cpk.	NPHP3 MYO5A	4.14e-05	4	92	2	1748176
Pubmed	Conserved and divergent functions of Nfix in skeletal muscle development during vertebrate evolution.	RYR1 RYR3	4.14e-05	4	92	2	23482488
Pubmed	Genetic mapping of the polycystic kidney gene, pcy, on mouse chromosome 9.	NPHP3 MYO5A	4.14e-05	4	92	2	8825940
Pubmed	Docking motif-guided mapping of the interactome of protein phosphatase-1.	PPP1R26 CAMSAP3 TSC2 CSMD1	6.22e-05	80	92	4	19389623
Pubmed	Hamartin and tuberin interaction with the G2/M cyclin-dependent kinase CDK1 and its regulatory cyclins A and B.	TSC2 CCNA2	6.89e-05	5	92	2	11444800
Pubmed	Fan1 deficiency results in DNA interstrand cross-link repair defects, enhanced tissue karyomegaly, and organ dysfunction.	FAN1 FANCA	6.89e-05	5	92	2	26980189
Pubmed	Follicular cells of the thyroid gland require Pax8 gene function.	TPO TG	6.89e-05	5	92	2	9590297
Pubmed	TAO-kinase 3 governs the terminal differentiation of NOTCH2-dependent splenic conventional dendritic cells.	TAOK3 ADAM10	6.89e-05	5	92	2	33214146
Pubmed	Presenilins regulate calcium homeostasis and presynaptic function via ryanodine receptors in hippocampal neurons.	RYR1 RYR3	6.89e-05	5	92	2	23918386
Pubmed	Microtubule minus-end stabilization by polymerization-driven CAMSAP deposition.	KATNB1 CAMSAP3	6.89e-05	5	92	2	24486153
Pubmed	Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells.	RYR1 RYR3	6.89e-05	5	92	2	19011160
Pubmed	Fanconi anemia protein complex is a novel target of the IKK signalsome.	IKBKB FANCA	6.89e-05	5	92	2	12210728
Pubmed	Membrane depolarization causes a direct activation of G protein-coupled receptors leading to local Ca2+ release in smooth muscle.	RYR1 RYR3	1.03e-04	6	92	2	19549818
Pubmed	Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos.	RYR1 RYR3	1.03e-04	6	92	2	26025922
Pubmed	Roles of I(f) and intracellular Ca2+ release in spontaneous activity of ventricular cardiomyocytes during murine embryonic development.	RYR1 RYR3	1.03e-04	6	92	2	23463619
Pubmed	Type 3 and type 1 ryanodine receptors are localized in triads of the same mammalian skeletal muscle fibers.	RYR1 RYR3	1.03e-04	6	92	2	10444070
Pubmed	Tuberin binds p27 and negatively regulates its interaction with the SCF component Skp2.	TSC2 CCNA2	1.03e-04	6	92	2	15355997
Pubmed	FKBP12.6 and cADPR regulation of Ca2+ release in smooth muscle cells.	RYR1 RYR3	1.03e-04	6	92	2	14592808
Pubmed	A calcium-induced calcium release mechanism supports luteinizing hormone-induced testosterone secretion in mouse Leydig cells.	RYR1 RYR3	1.03e-04	6	92	2	20519450
Pubmed	A mouse model demonstrates a multigenic origin of congenital hypothyroidism.	TPO TG	1.03e-04	6	92	2	16150900
Pubmed	Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging.	RYR1 RYR3	1.03e-04	6	92	2	25966694
Pubmed	HIV-1 Tat activates neuronal ryanodine receptors with rapid induction of the unfolded protein response and mitochondrial hyperpolarization.	RYR1 RYR3	1.03e-04	6	92	2	19009018
Pubmed	15q13.3 Recurrent Deletion	TRPM1 FAN1	1.03e-04	6	92	2	21290787
Pubmed	IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1.	RYR1 RYR3	1.03e-04	6	92	2	16844763
Pubmed	Molecular characteristics in papillary thyroid cancers (PTCs) with no 131I uptake.	TPO TG	1.03e-04	6	92	2	17854396
Pubmed	Secreted heat shock protein 90α (HSP90α) induces nuclear factor-κB-mediated TCF12 protein expression to down-regulate E-cadherin and to enhance colorectal cancer cell migration and invasion.	LRP1 IKBKB	1.03e-04	6	92	2	23386606
Pubmed	FOXL2 modulates cartilage, skeletal development and IGF1-dependent growth in mice.	KLF9 FGFR2 RYR1	1.41e-04	38	92	3	26134413
Pubmed	Sulfatases and sulfatase modifying factors: an exclusive and promiscuous relationship.	ARSJ ARSI	1.44e-04	7	92	2	16174644
Pubmed	Role of myosin VIIa and Rab27a in the motility and localization of RPE melanosomes.	MYO5A PCDH15	1.44e-04	7	92	2	15572405
Pubmed	ADAM binding protein Eve-1 is required for ectodomain shedding of epidermal growth factor receptor ligands.	SH3D19 ADAM10	1.44e-04	7	92	2	15280379
Pubmed	Developmental expression of the calcium release channels during early neurogenesis of the mouse cerebral cortex.	RYR1 RYR3	1.44e-04	7	92	2	11860456
Pubmed	NLRX1 negatively regulates TLR-induced NF-κB signaling by targeting TRAF6 and IKK.	NLRX1 IKBKB	1.44e-04	7	92	2	21703539
Pubmed	Human immunodeficiency virus-1 Tat activates calpain proteases via the ryanodine receptor to enhance surface dopamine transporter levels and increase transporter-specific uptake and Vmax.	RYR1 RYR3	1.44e-04	7	92	2	20962236
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	NAA25 FBH1 MYO5A SH3D19 POLR1C DEF8 LRP1 TSC2 PC RYR3 AGAP2 FAN1	1.46e-04	1285	92	12	35914814
Pubmed	Myogenic-specific ablation of Fgfr1 impairs FGF2-mediated proliferation of satellite cells at the myofiber niche but does not abolish the capacity for muscle regeneration.	FGFR2 ITGA7	1.92e-04	8	92	2	26074812
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	PPP1R26 CAMSAP3 TSC2 CSMD1 RYR1 PPP1R1A	2.96e-05	181	60	6	694
GeneFamily	Ryanodine receptors\|Protein phosphatase 1 regulatory subunits	RYR1 RYR3	3.24e-05	3	60	2	287
GeneFamily	Shisa family members	SHISA9 SHISA3	2.99e-04	8	60	2	742
GeneFamily	DNA helicases	FBH1 RTEL1	1.43e-03	17	60	2	1167
GeneFamily	Sulfatases	ARSJ ARSI	1.60e-03	18	60	2	410
GeneFamily	CD molecules\|Integrin alpha subunits	ITGA11 ITGA7	1.60e-03	18	60	2	1160
GeneFamily	Mitochondrial ribosomal proteins	MRPL27 MRPL28 MRPL9	2.30e-03	79	60	3	646
GeneFamily	Transient receptor potential cation channels	TRPM5 TRPM1	3.87e-03	28	60	2	249
Coexpression	GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG2_AND_FOXP3_TRASDUCED_UP	ARSJ CCDC78 SPG11 FLRT1 PTGDR FAN1	1.20e-05	144	92	6	M9003
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HRGL2C	DNAAF3 TAOK3 SH3D19 LRP1 CSMD1 CENPK PHGDH SHISA3	1.93e-05	325	92	8	M39053
Coexpression	HE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL	REC8 ASNSD1 TOR2A MTHFD2 KATNB1 MRPL27 RBM15B FAM83D CEP131 AP4M1 DCTPP1 CENPK MRPL9 PHGDH CCNA2 FANCA	1.96e-05	1363	92	16	M45782
Coexpression	PARENT_MTOR_SIGNALING_UP	GALT CATSPER2 RTEL1 TMC6 LRP1 TSC2 DGKH FLRT1 ITGA7 PHGDH	3.05e-05	567	92	10	M16909
ToppCell	368C-Lymphocytic-CD4_T-cell-Treg_cell_1\|368C / Donor, Lineage, Cell class and subclass (all cells)	TCAF2 UTS2 ZC3H12D AKNA DGKH IKBKB	6.46e-07	148	92	6	80470353e12599440f711b6e107730763376d04d
ToppCell	PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	UBXN11 FAM83D ZBTB18 CCNA2 BORA FANCA	1.50e-06	171	92	6	6e7ade1d14a3ec4c566476aac3eb509bd2661e39
ToppCell	COVID-19-Heart-T_cell\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SGCZ PCDH15 CSMD1 PTGDR RYR1 RYR3	1.50e-06	171	92	6	b2e753e811a7639956994609f73efcdb62d04f82
ToppCell	E12.5-Mesenchymal-developing_mesenchymal_cell\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MTHFD2 FAM83D DCTPP1 CENPK CCNA2 BORA	3.21e-06	195	92	6	97b2ff072cc830a4a2cb217f5a215ca6cad505ec
ToppCell	facs-Pancreas-Exocrine-18m-Epithelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	REC8 SGCZ CAMSAP3 DEF8 RAPGEFL1	9.67e-06	137	92	5	e9b88ad86b75454a8292a94879c5b665adc42744
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SGCZ PCDH15 TRPM1 CSMD1 RYR1	2.51e-05	167	92	5	3edb0570e583bb527165bcd8a4c25a042054043b
ToppCell	P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PPP1R26 DHRS13 DCTPP1 CENPK CCNA2	2.90e-05	172	92	5	7c238a7375341d4647ba7274d93fddfb6fae7ce4
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TPO TCAF2 ITGA11 ARSJ RYR3	3.06e-05	174	92	5	43c0e758fa8683708475aec846929ac70d41d7f5
ToppCell	MS-Treg-naive_CD4\|MS / Condition, Cell_class and T cell subcluster	UTS2 DGKH PRR14L CENPK CCNA2	3.60e-05	180	92	5	7ca083616926d98420fa11a6e5ebc981623f79ac
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TPO ADAMTS19 ITGA11 ARSJ RYR3	3.60e-05	180	92	5	e8841ef1239f9ee73ac4f4e11faca0742694f368
ToppCell	10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8\|Liver / Manually curated celltypes from each tissue	KANSL1 ZC3H12D DGKH ANKRD12 IKBKB	3.69e-05	181	92	5	f2315414e714ac86211546a935660c4be6e85f1b
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TPO ADAMTS19 ITGA11 ARSJ RYR3	3.79e-05	182	92	5	72e65a23cd36085bc880087d3cae92395de918a1
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TPO ADAMTS19 ITGA11 ARSJ RYR3	3.79e-05	182	92	5	05c167158815bf25d509df59ab386e1990712765
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FAM83D CENPK CCNA2 BORA FANCA	4.10e-05	185	92	5	30e041d6f6e310d64809e9d6d93cd30052972f3b
ToppCell	Smart-seq2-bone_marrow_(Smart-seq2)-hematologic-hematopoietic_progenitor-common_myeloid_progenitor\|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	DNAAF3 FAM83D PGAP4 DCTPP1 RYR3	4.10e-05	185	92	5	eac18ddcdac60b829619f7657e833d08cc9bcbab
ToppCell	droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	REC8 SHISA9 TCAF2 NUMBL FLRT1	4.65e-05	190	92	5	3cf464664d6aa22b212e60b70885953887e92483
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FAM83D CENPK PHGDH CCNA2 FANCA	4.77e-05	191	92	5	50854384fdaa0efa2e3227659d544ed09ac102f2
ToppCell	P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	FAM83D DCTPP1 CENPK PHGDH CCNA2	4.77e-05	191	92	5	b978afe76754cc56e1672abca27be289bb56375b
ToppCell	Non-neuronal-Dividing-Radial_Glia-Low_Quality-16\|World / Primary Cells by Cluster	FAM83D CENPK PHGDH CCNA2 BORA	4.89e-05	192	92	5	0d6413df15dfecdffc777fb02df3aaf0c30540b1
ToppCell	Non-neuronal-Dividing-Radial_Glia-Low_Quality\|World / Primary Cells by Cluster	FAM83D CENPK PHGDH CCNA2 BORA	4.89e-05	192	92	5	5fa5b2f250ec5ad5a232c022266f0cd01ff4a753
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	SGCZ ITGA11 MTHFD2 CENPK FANCA	5.01e-05	193	92	5	516ea2c12bdc7a5dc676159d627e36f6abe13ef0
ToppCell	facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SGCZ TRPM5 MTHFD2 PC PPP1R1A	5.26e-05	195	92	5	58b769da05a8f6b05aeb08d4f8b112941087ad00
ToppCell	facs-Thymus-Thymus_Epithelium\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KLF9 PCDH15 LRP1 CSMD1 RYR3	5.39e-05	196	92	5	6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363
ToppCell	facs-Thymus-Thymus_Epithelium-18m\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KLF9 PCDH15 LRP1 CSMD1 RYR3	5.39e-05	196	92	5	c8c89e469402e11aa2a9561e859b6fd1fb66c39b
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors\|3.5_mon / Sample Type, Dataset, Time_group, and Cell type.	FAM83D CENPK PHGDH CCNA2 BORA	5.39e-05	196	92	5	5905f0e3061a6b98b7a33d64c782c3dda2cd51ef
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ARSJ FAM83D CENPK CCNA2 SHISA3	5.66e-05	198	92	5	1fa213e79d828bff6465bde116536dd1b80d94e0
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	FAM83D CEP131 CENPK CCNA2 BORA	5.66e-05	198	92	5	629d674a9c9108c1acb3f7af57bbdbf34bb0528e
ToppCell	Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	RPAP1 FAM83D ITGA7 ARMC2 PPP1R1A	5.66e-05	198	92	5	cc2b5b632e73e44bb60050f0db10d8f0dbb859fa
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Proliferating-cycling_dorsal_progenitors\|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.	FAM83D CENPK PHGDH CCNA2 BORA	5.66e-05	198	92	5	dada1c19a261c8e1090957cd7e37f2a43a9fe14f
ToppCell	Non-neuronal-Dividing-IPC-IPC-div1-28\|World / Primary Cells by Cluster	FAM83D CENPK PHGDH CCNA2 BORA	5.79e-05	199	92	5	787688b68ae5d8768c0a24673ae07ab07616764a
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW12-OPC_related-OPC\|GW12 / Sample Type, Dataset, Time_group, and Cell type.	RTEL1 ESYT1 SH3D19 PCDH15 SHISA3	5.79e-05	199	92	5	c0dc14fb9899d4263264347436de121814441dfb
ToppCell	Non-neuronal-Dividing-IPC-IPC-div1\|World / Primary Cells by Cluster	FAM83D CENPK PHGDH CCNA2 BORA	5.79e-05	199	92	5	72823f26ecabcae1b514b7629cfce010c97b929a
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating-cycling_dorsal_progenitors\|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.	FAM83D CENPK PHGDH CCNA2 BORA	5.79e-05	199	92	5	ca17e8c0f5bc2c41ce28351a7418d934404e563b
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_basal-Dividing_Basal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	FAM83D FGFR2 CENPK CCNA2 RAPGEFL1	5.79e-05	199	92	5	fe22833e69928a1478df265e1c356c463611dedd
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating\|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.	FAM83D CENPK PHGDH CCNA2 BORA	5.79e-05	199	92	5	d8f904f531bfe091b7d8caaa147ea4a03d627995
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW12-OPC_related\|GW12 / Sample Type, Dataset, Time_group, and Cell type.	RTEL1 ESYT1 SH3D19 PCDH15 SHISA3	5.79e-05	199	92	5	9bc53ff93ca97af4ee0f01c74a567987a26abb18
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FAM83D CENPK ARSI CCNA2 SHISA3	5.93e-05	200	92	5	dd5b753bb1333fa502b9d3a6d65a53a9882b2451
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	FAM83D CENPK PHGDH CCNA2 BORA	5.93e-05	200	92	5	762442d125e594fede4506b72da15563b1d8798a
ToppCell	severe-T/NK_proliferative\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	DCTPP1 CENPK PHGDH CCNA2 FANCA	5.93e-05	200	92	5	d341f4e500377a5bef82c24bf64704b981053336
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LRP1 FGFR2 ARSI TPBG SHISA3	5.93e-05	200	92	5	3dacd0afe69bc16bb33336ea9ea99a9cd47731d9
ToppCell	Non-neuronal-Dividing-IPC\|World / Primary Cells by Cluster	FAM83D CENPK PHGDH CCNA2 BORA	5.93e-05	200	92	5	971533181daa1bfac1f1b8c507d2013f891f9078
ToppCell	Non-neuronal-Dividing-Radial_Glia-vRG-17\|World / Primary Cells by Cluster	FAM83D CENPK PHGDH CCNA2 BORA	5.93e-05	200	92	5	4417f14d45ce683c1a45ec989ae63ee6c047353e
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW12-Stem_cells\|GW12 / Sample Type, Dataset, Time_group, and Cell type.	FAM83D CENPK PHGDH CCNA2 BORA	5.93e-05	200	92	5	0bba93f1271dac704dddcdea8cb0f84a7ac6f42a
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LRP1 FGFR2 ARSI TPBG SHISA3	5.93e-05	200	92	5	ac8a5d71acd4d401995babd233f0d3738e8ad2a5
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors_nGenesUnder4k\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	FAM83D CENPK PHGDH CCNA2 BORA	5.93e-05	200	92	5	243c7f88befd402a57e9226706811c802b28e3fd
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW12-Stem_cells-Neuroepithelial_cell\|GW12 / Sample Type, Dataset, Time_group, and Cell type.	FAM83D CENPK PHGDH CCNA2 BORA	5.93e-05	200	92	5	c9479452ab8c51139522383f745f02171ebbd7e2
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_C1ql2_Ptgfr\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	RAVER2 RYR1 RYR3 TPBG	1.40e-04	127	92	4	fb58f4b4d3722f4b9a2e4946c0244c5b70dd883b
ToppCell	E16.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_smooth_muscle-like\|E16.5-samps / Age Group, Lineage, Cell class and subclass	TPO RAVER2 PCDH15 PPP1R1A	1.62e-04	132	92	4	9633653dba1edee47d915212fb6e68426da49de5
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SGCZ RAVER2 RYR1 RYR3	1.72e-04	134	92	4	cb676d5bbc468bd3ce1b6712d41c986ee9221ac5
ToppCell	E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_2\|E16.5-samps / Age Group, Lineage, Cell class and subclass	SHISA9 NKX2-8 RIOX1 RYR3	1.92e-04	138	92	4	05de2cef97c0912fb23f138dd45348f565a14d74
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Epi-like-Gen_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CAMSAP3 LRP1 FGFR2 TG	2.14e-04	142	92	4	d52da766e031f7409eb5a7a9fa88f48e14a79d8b
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Epi-like\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CAMSAP3 LRP1 FGFR2 TG	2.14e-04	142	92	4	a05b320cf182b2aaf18df7c40045dc65b659bf20
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	UBXN11 RAVER2 ZBTB18 RYR1	2.20e-04	143	92	4	5fb5a4ea93e5cce55d427e3b4a50a979504fad3c
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_3\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IL17B CSMD1 ITGA7 METTL17	2.38e-04	146	92	4	2ac9b487a7991fdc15444aeb93533030e09825bb
ToppCell	Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2\|Hippocampus / BrainAtlas - Mouse McCarroll V32	RAVER2 ZBTB18 RYR3 AGAP2	2.44e-04	147	92	4	8f725ff8fb4ced5db2643e80669d3f7945b820ab
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	NKX2-8 KANSL1 AKNA DGKH	2.44e-04	147	92	4	94998bc40f5c08295cfe3bdcbe43f13b1e564b3d
ToppCell	droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NLRX1 LRP1 DGKH RYR1	2.78e-04	152	92	4	82a493ffb2f1704cd6f68a82d970fe12f537d20e
ToppCell	PBMC-Control-cDC_8\|Control / Compartment, Disease Groups and Clusters	NPHP3 FAM83D RIOX1 RAPGEFL1	2.85e-04	153	92	4	db1a6914f2033fb0748e0523cffe5d6dc4e901be
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	UBXN11 DHRS13 RIOX1 CCNA2	2.85e-04	153	92	4	991782d111d66e25b40319d4e6dea40f2c2c0805
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SGCZ KATNB1 PTGDR RAPGEFL1	2.99e-04	155	92	4	51f6447945389649d99dcf7603b396195c631ead
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic-Mast_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SGCZ KATNB1 PTGDR RAPGEFL1	2.99e-04	155	92	4	23dc71cab28094ca0ac4d2baf4e24871ed107781
ToppCell	10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8\|bone_marrow / Manually curated celltypes from each tissue	KANSL1 ZC3H12D DGKH ANKRD12	3.07e-04	156	92	4	1545169694f686d28648a68b552c2ae606599d66
ToppCell	LPS-IL1RA-Hematopoietic_Meg-Ery-Mes-Epi-like\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SGCZ KATNB1 CAMSAP3 RBM15B	3.14e-04	157	92	4	bd45590da540a557dc8096980a45220fccb99505
ToppCell	LPS-IL1RA-Hematopoietic_Meg-Ery-Mes-Epi-like-Erythroid\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SGCZ KATNB1 CAMSAP3 RBM15B	3.14e-04	157	92	4	00c9a58b033b8b95b0d838f233dd077b62d8b02a
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	POLR1C PCDH15 CCNA2 FAN1	3.22e-04	158	92	4	7f5426585d0d299d2b48e5fcb349950feffdef33
ToppCell	Bac-SEP-Lymphocyte-T_NK-NK_CD56bright\|Bac-SEP / Disease, Lineage and Cell Type	RPAP1 CCDC78 PTGDR MRPL9	3.22e-04	158	92	4	20411158d71699a80f6c1566791af89dea0e1875
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	SGCZ PCDH15 CSMD1 RYR1	3.29e-04	159	92	4	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	COVID-CD4-CD4_Treg\|COVID / Condition, Cell_class and T cell subcluster	RAVER2 SPG11 TPBG FANCA	3.29e-04	159	92	4	037cd97c41eb2f91fd3f69bbb3ffdfd6c0158410
ToppCell	10x5'-Lung-Lymphocytic_NK-NK_CD56bright_CD16-\|Lung / Manually curated celltypes from each tissue	CCDC78 AKNA DHRS13 PPP1R1A	3.29e-04	159	92	4	595643e9433265308e5aab7f906229025701cf6a
ToppCell	E15.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PPP1R26 UBXN11 CEP131 ARSI	3.45e-04	161	92	4	9703b7e67d9fadb6129cad166bd01be915042e44
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma\|TCGA-Brain / Sample_Type by Project: Shred V9	TAOK3 PCDH15 PC RYR1	3.45e-04	161	92	4	347edb0de10850b7d16c40945751033289289c9b
ToppCell	droplet-Heart-nan-18m-Hematologic-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CENPK RYR1 CCNA2 FANCA	3.54e-04	162	92	4	7f425a3983325a5a3ea33f812b15aa010cc55de0
ToppCell	facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADAMTS19 ITGA11 AP4M1 PTGDR	3.54e-04	162	92	4	56f1789e69a6cb29956e46aba92b290847327c1f
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c02-NCAM1\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CATSPER2 ESYT1 POLR1C CEP131	3.62e-04	163	92	4	1c014e373667be290d7fb5d24c06c6f313ac8fa3
ToppCell	facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	REC8 SGCZ MYO5A DEF8	3.62e-04	163	92	4	132aece9c79499b4bb3c2bde68d3d7202e1d8772
ToppCell	droplet-Lung-21m-Hematologic-myeloid-intermediate_monocyte\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DNAAF3 MTHFD2 LRP1 RAPGEFL1	3.70e-04	164	92	4	cd0794f84dfd346807e2d803723718b7f22e9232
ToppCell	droplet-Lung-21m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DNAAF3 MTHFD2 LRP1 RAPGEFL1	3.70e-04	164	92	4	12251a49fd4af32d4edb58046245548c260cf04b
ToppCell	356C-Myeloid-Monocyte-CD16+_Monocyte\|356C / Donor, Lineage, Cell class and subclass (all cells)	PPP1R26 FKBP6 CATSPER2 TG	3.79e-04	165	92	4	35a6de30438de364ccca948fc932da541a69ef89
ToppCell	droplet-Liver-LIVER-NPC-1m-Lymphocytic-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NPHP3 UBXN11 KATNB1 IKBKB	3.79e-04	165	92	4	8c7a6f9e2ca0ce077426d3d0726e3f5a4c03b296
ToppCell	facs-Heart-RA-24m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZC3H12D PHGDH RYR1 TG	3.79e-04	165	92	4	36415924d05373e9dd3665be599f4f3f40bf0497
ToppCell	facs-Heart-RA-24m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZC3H12D PHGDH RYR1 TG	3.79e-04	165	92	4	56310fddd3d8e4afdfde066d26cee9747e5b8c6a
ToppCell	droplet-Fat-SCAT-30m-Lymphocytic-B_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZC3H12D PHGDH FAN1 TG	3.88e-04	166	92	4	4b31d2755108b2815316411a38bfb11fd30ef98a
ToppCell	10x5'-bone_marrow-Hematopoietic_progenitors-Progenitor_pre-Lymphocytic-T\|bone_marrow / Manually curated celltypes from each tissue	TOR2A RAVER2 CSMD1 PHGDH	3.88e-04	166	92	4	20f248d95c86eb52a1efe9abe73123fbe4206caf
ToppCell	Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Bdnf_(Deep_layer_pyramidal_cells)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	CCDC78 ZC3H12D FANCA	3.93e-04	69	92	3	24a480394630385ee51b1dfe1123480107a11403
ToppCell	Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Bdnf_(Deep_layer_pyramidal_cells)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	CCDC78 ZC3H12D FANCA	3.93e-04	69	92	3	1ab1d92e03a31bb1fe87f055d407a81c4d1d81b8
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	TPO PCDH15 ITGA7	3.93e-04	69	92	3	1592edde44c3927d6a2350eb00f92c10d3adf692
ToppCell	356C-Myeloid-Monocyte-CD16+_Monocyte\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	PPP1R26 FKBP6 CATSPER2 TG	3.97e-04	167	92	4	7e61c5d2cdcfa6a2e3484b3994aec6b64ad75f07
ToppCell	facs-Lung-Endomucin-24m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZC3H12D CENPK PHGDH AGAP2	3.97e-04	167	92	4	4520ee71e2b119c1dfa0e342fe57eda5f3598650
ToppCell	368C-Myeloid-Dendritic-pDC\|368C / Donor, Lineage, Cell class and subclass (all cells)	NAA25 RPAP1 AGAP2 BORA	3.97e-04	167	92	4	1e2fc1637769405a61f4c7e44945712a1888a299
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c03-MKI67\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RAVER2 DHRS13 CEP131 CCNA2	3.97e-04	167	92	4	9280558baddea51aae47f3383d895a9b0c6749a4
ToppCell	droplet-Liver-Npc-18m-Lymphocytic-B_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO5A PHGDH TPBG TG	4.06e-04	168	92	4	ce9fae8b295c668b0959d5007a8bcd401d80e258
ToppCell	facs-Limb_Muscle-forelimb_and_hindlimb-18m-Lymphocytic-T_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RTEL1 AKNA FAM83D IKBKB	4.06e-04	168	92	4	182f08106ac65ea501e2fb9139d3b44b7c4662c9
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_SLITRK6\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SGCZ ARSJ PCDH15 RYR3	4.15e-04	169	92	4	1c9e54e7b14eb99996590fb93b257cf881a9f184
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FAM83D CENPK CCNA2 FANCA	4.15e-04	169	92	4	b253a4a50c06d36228fcd5d856c57202cbac158f
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KANSL1 ADAM10 ZBTB18 FANCA	4.15e-04	169	92	4	4e1322cc5e1733e9fb19e08f739a30206f43cea8
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	BCLAF3 RPAP1 CATSPER2 SPG11	4.15e-04	169	92	4	665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5
ToppCell	droplet-Kidney-nan-18m-Epithelial-Pecam____kidney_capillary_endothelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCAF2 TBC1D30 DGKH SHISA3	4.15e-04	169	92	4	87116c33c5ca8cb1862e103e5607b1df4d264569
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DGKH CENPK CCNA2 BORA	4.15e-04	169	92	4	2833a8a7094e4d407eb923f2bc59b9b112c6bae4
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	BCLAF3 RPAP1 CATSPER2 SPG11	4.15e-04	169	92	4	6614c9851537e4c21b1e45ff0cc3bad07ef9d034
ToppCell	Basal_cells-SSc-ILD_02\|World / lung cells shred on cell class, cell subclass, sample id	DGKH TPBG RAPGEFL1 TG	4.24e-04	170	92	4	776d4224a682b6c648041827efd69794f88906f0
Drug	perchlorate	TPO AP4M1 PC RYR1 RYR3 TG	1.75e-06	90	92	6	CID000024247
Drug	5'-adenylyl (beta,gamma-methylene)diphosphonate	RYR1 RYR3	1.62e-05	2	92	2	ctd:C005147
Drug	Cefotetan [69712-56-7]; Down 200; 7uM; HL60; HT_HG-U133A	RPAP1 KLF9 NLRX1 TMC6 KATNB1 AP4M1 FANCA	1.64e-05	199	92	7	1319_DN
Drug	bimoclomol	IKBKB RYR1 RYR3	2.25e-05	14	92	3	CID009576891
Drug	2-hydroxycarbazole	RYR1 RYR3	4.83e-05	3	92	2	CID000093551
Drug	1,1'-diheptyl-4,4'-bipyridinium	RYR1 RYR3	4.83e-05	3	92	2	CID000080262
Drug	cis-diammineplatinum(II	RYR1 RYR3	4.83e-05	3	92	2	CID000159790
Drug	2-hydroxyheptanoic acid	RYR1 RYR3	4.83e-05	3	92	2	CID002750949
Drug	flubendiamide	RYR1 RYR3	4.83e-05	3	92	2	CID011193251
Drug	Ryanodyl 3-(pyridine-3-carboxylate	RYR1 RYR3	4.83e-05	3	92	2	CID005748312
Drug	8N3-cADPR	RYR1 RYR3	4.83e-05	3	92	2	CID000127713
Drug	aminodantrolene	RYR1 RYR3	4.83e-05	3	92	2	CID009570289
Disease	Congenital Fiber Type Disproportion	CCDC78 ITGA7 RYR1	2.17e-05	18	90	3	C0546264
Disease	congenital myopathy 1A (implicated_via_orthology)	RYR1 RYR3	2.75e-05	3	90	2	DOID:3529 (implicated_via_orthology)
Disease	malignant hyperthermia (implicated_via_orthology)	RYR1 RYR3	2.75e-05	3	90	2	DOID:8545 (implicated_via_orthology)
Disease	diet measurement, bilirubin measurement	SH3D19 IL17B RAVER2	6.78e-05	26	90	3	EFO_0004570, EFO_0008111
Disease	Thyroid Dyshormonogenesis 1	TPO TG	1.37e-04	6	90	2	C1848805
Disease	phosphate measurement	MTHFD2 RYR3	1.91e-04	7	90	2	EFO_0010968
Disease	Goiter	TPO TG	1.91e-04	7	90	2	C0018021
Disease	Ciliopathies	DNAAF3 NPHP3 PCDH15 TSC2	3.65e-04	110	90	4	C4277690
Disease	Congenital muscular dystrophy	ITGA7 RYR1	5.95e-04	12	90	2	cv:C0699743
Disease	Autosomal Dominant Myotubular Myopathy	CCDC78 RYR1	7.02e-04	13	90	2	C3661489
Disease	cardiomyopathy (biomarker_via_orthology)	UTS2 ADAM10	7.02e-04	13	90	2	DOID:0050700 (biomarker_via_orthology)
Disease	Centronuclear myopathy	CCDC78 RYR1	7.02e-04	13	90	2	C0175709
Disease	X-linked centronuclear myopathy	CCDC78 RYR1	7.02e-04	13	90	2	C0410203
Disease	male infertility (implicated_via_orthology)	FKBP6 ARMC2	7.02e-04	13	90	2	DOID:12336 (implicated_via_orthology)
Disease	Myopathy, Centronuclear, 1	CCDC78 RYR1	7.02e-04	13	90	2	C4551952
Disease	Congenital Hypothyroidism	TPO TG	7.02e-04	13	90	2	C0010308
Disease	Congenital Structural Myopathy	CCDC78 RYR1	7.02e-04	13	90	2	C0752282
Disease	Alzheimer's disease (biomarker_via_orthology)	LRP1 IKBKB ADAM10	7.50e-04	58	90	3	DOID:10652 (biomarker_via_orthology)
Disease	Myopathy, Centronuclear, Autosomal Dominant	CCDC78 RYR1	8.17e-04	14	90	2	C1834558
Disease	Tubular Aggregate Myopathy	CCDC78 RYR1	8.17e-04	14	90	2	C0410207
Disease	central nervous system cancer, glioblastoma multiforme	RTEL1 RAVER2	8.17e-04	14	90	2	EFO_0000326, EFO_0000519
Disease	congenital hypothyroidism (implicated_via_orthology)	TPO TG	8.17e-04	14	90	2	DOID:0050328 (implicated_via_orthology)
Disease	Profound Mental Retardation	KANSL1 FGFR2 AP4M1 CCNA2	8.81e-04	139	90	4	C0020796
Disease	Mental Retardation, Psychosocial	KANSL1 FGFR2 AP4M1 CCNA2	8.81e-04	139	90	4	C0025363
Disease	Mental deficiency	KANSL1 FGFR2 AP4M1 CCNA2	8.81e-04	139	90	4	C0917816
Disease	Anilide use measurement	KANSL1 LRP1	9.41e-04	15	90	2	EFO_0009938
Disease	Autosomal Recessive Centronuclear Myopathy	CCDC78 RYR1	9.41e-04	15	90	2	C3645536
Disease	magnesium measurement	ADAMTS19 SGCZ FGFR2	1.09e-03	66	90	3	EFO_0004845
Disease	joint damage measurement	SGCZ CSMD1 TG	1.19e-03	68	90	3	EFO_0005413
Disease	cardiomyopathy (implicated_via_orthology)	SGCZ LRP1 ITGA7	1.35e-03	71	90	3	DOID:0050700 (implicated_via_orthology)
Disease	obsessive-compulsive disorder, autism spectrum disorder	SGCZ DEF8	1.52e-03	19	90	2	EFO_0003756, EFO_0004242
Disease	behavioural disinhibition measurement	ARSJ CSMD1 SHISA3	1.58e-03	75	90	3	EFO_0006946
Disease	nicotine dependence symptom count, depressive symptom measurement	ITGA11 PCDH15 PHGDH	1.58e-03	75	90	3	EFO_0007006, EFO_0009262
Disease	memory performance	DNAAF3 SGCZ TBC1D30 CSMD1 ARMC2 PHGDH	1.60e-03	409	90	6	EFO_0004874
Disease	acetate measurement	CATSPER2 SPG11	1.69e-03	20	90	2	EFO_0010112
Disease	pulmonary hypertension (biomarker_via_orthology)	UTS2 RYR1 RYR3	1.90e-03	80	90	3	DOID:6432 (biomarker_via_orthology)
Disease	glioma	RTEL1 RAVER2	2.04e-03	22	90	2	EFO_0005543
Disease	sensory peripheral neuropathy, remission	SGCZ CSMD1	2.23e-03	23	90	2	EFO_0009785, MONDO_0002321
Disease	airway responsiveness measurement	PCDH15 CSMD1	2.43e-03	24	90	2	EFO_0006897
Disease	response to radiation	NUMBL CSMD1 TPBG	2.50e-03	88	90	3	GO_0009314
Disease	TEMPS-A questionnaire	SGCZ CSMD1	2.64e-03	25	90	2	EFO_0004783

Protein segments in the cluster

Peptide	Gene	Start	Entry
APELRQRLTHVDSPL	ESYT1	951	Q9BSJ8
REENEILPPDHLNGV	SDF4	51	Q9BRK5
SQAVPRHTIRELLDP	CATSPER2	36	Q96P56
RQPETPAHADVRAID	CSMD1	3276	Q96PZ7
IPQEEHAANGPELLR	ADAM10	196	O14672
RASPRTEILHNIDPL	ARSI	381	Q5FYB1
HRAQRPPSEAEDVLI	ARMC2	591	Q8NEN0
VEDPQLRSPLHLAAE	AGAP2	1086	Q99490
IRLTEDDDPQIHHPR	ANKRD12	1771	Q6UB98
ALPERPVREADLRHQ	CAMSAP3	116	Q9P1Y5
LDEFESHRILRLQPP	AP4M1	261	O00189
TAAAIPRRHAPLEQL	NUMBL	286	Q9Y6R0
PAALHPEEVAARLQR	RAVER2	46	Q9HCJ3
RNLDADLVRDRTPPH	RBM15B	521	Q8NDT2
DIPQIRHLLEAAIPE	REC8	151	O95072
REASPQPLEELDHLL	PTGDR	251	Q13258
QHAEPDGDEVLLRIP	ADAMTS19	156	Q8TE59
EHGVAPDAERLRLPE	KLF9	26	Q13886
LDVVERSPHRPILQA	FGFR2	246	P21802
NHDPSRIPVDLPEAR	IL17B	106	Q9UHF5
RRLTHPNVVAARDVP	IKBKB	66	O14920
IEHPRAIALDPRDGI	LRP1	1386	Q07954
LRSPRVDILHNIDPI	ARSJ	411	Q5FYB0
QQRPPVDEVLREGHI	KIAA1109	871	Q2LD37
VARDPVQDHRPLAQP	KATNB1	311	Q9BVA0
ENRVALHALTRPPAL	NAT14	31	Q8WUY8
VRRLDASFQEHPDLP	TPO	501	P07202
NPDEVHAILRAAERP	FAM83D	61	Q9H4H8
EELTRADPEQRHVPL	KANSL1	416	Q7Z3B3
TPVEEDLRRAPQLNH	ITGA11	1046	Q9UKX5
PEEQIFPVLEHLLRA	PGAP4	216	Q9BRR3
DELLRPPAELALEHQ	NLRX1	121	Q86UT6
DLPEQDAQHLPRREP	NKX2-8	16	O15522
VGRVPLQLESPHEER	DGKH	1066	Q86XP1
LRRRSAPPEEQHLVE	FKBP6	201	O75344
HPRTAELSLLEPVNR	PCDH15	341	Q96QU1
RDHPLLPEAEACVRQ	FBH1	316	Q8NFZ0
EIPLNSDPEIHRRID	BCLAF3	511	A2AJT9
RAQADLLAHLVPEPD	DNAAF3	131	Q8N9W5
LLAHLVPEPDRLEEQ	DNAAF3	136	Q8N9W5
PEQAAERLRALPEVH	GALT	351	P07902
INTPRLEPREHMAVD	FANCA	706	O15360
INPVEIDPEDIHRQA	BORA	66	Q6PGQ7
LEILINRLFDVPHDP	CENPK	216	Q9BS16
VEDRPQDPLARLRHK	AKNA	736	Q7Z591
ESDPRHPRAAAQELR	CCDC78	116	A2IDD5
RHIPLDEPIDLLNVA	ASNSD1	341	Q9NWL6
DPNEDEPNIRVLLEH	DEF8	186	Q6ZN54
PRPNILHLDVDSRDR	ITGA7	941	Q13683
SPEPTLEDIRRLHAE	DCTPP1	26	Q9H773
DEFPINLPRSLRELH	FLRT1	91	Q9NZU1
RVAPLKDLPVNDEHV	CCNA2	71	P20248
HEAVLPRERLHLEPI	RYR1	811	P21817
DHLEELLEQHRRPTP	CEP131	1066	Q9UPN4
SRHLPVEPEELQRRA	METTL17	96	Q9H7H0
HVEEVPPAARDDRAA	DHRS13	286	Q6UX07
HPPLEGRADVIADIQ	PRR14L	691	Q5THK1
PALEARLQLIHDAPE	FAN1	881	Q9Y2M0
EHSIPRRQRAQPVLD	RTEL1	981	Q9NZ71
PHEDARLTPEELERA	UTS2	36	O95399
IITPLDEHLRSRPND	SH3D19	471	Q5HYK7
AQAHEALSPPERERR	TCAF2	796	A6NFQ2
PEHIDERRICNAVSP	MTHFD2	136	P13995
EIRETALDPDHPRVA	NPHP3	971	Q7Z494
DRRELEHPGITAQPV	SHISA3	81	A0PJX4
NLPLHPVRVEDEPRA	SHISA9	321	B4DS77
IPQERPTSAELLRHD	TAOK3	261	Q9H2K8
RVQLREERAPDPPAH	PPP1R26	391	Q5T8A7
ETPHIRAEPSQDLRL	SGCZ	181	Q96LD1
RPVHDDILIAQLRPG	POLR1C	191	O15160
IHDSLPPVLTDRERA	RIOX1	506	Q9H6W3
VQELLRPRHEGNAPD	MRPL9	26	Q9BYD2
LEEEAPDIPLRRVHS	SPG11	1941	Q96JI7
ELEPVISRAVLDNPH	TOR2A	226	Q5JU69
REHLERDLPDPLDQK	TRPM5	1036	Q9NZQ8
LPPHLEKIRDRLAEN	RYR3	861	Q15413
PAHLAPLREDSVLRE	ZBTB18	311	Q99592
RQDPQLHPEDPERRA	MRPL28	171	Q13084
QRDAAAETELRVHPP	TBC1D30	826	Q9Y2I9
DRPPLQDHRDVVMLD	RPAP1	46	Q9BWH6
PRADTPIREQHVLAE	ZC3H12D	141	A2A288
QDEHHVAEAIPRIPR	TRPM1	1506	Q7Z4N2
PPRDRALVDHENVIS	PHGDH	266	O43175
PRDVLAQLPSLRHLD	TPBG	226	Q13641
RVLAALEPHDSPVLE	TMC6	491	Q7Z403
PHPRNTEAVDLITRL	MRPL27	106	Q9P0M9
GAPERPEHLLNRVLE	RAPGEFL1	146	Q9UHV5
PVASLPDLHDIERAL	TG	1376	P01266
LLEPHLDPEAAEQIR	PPP1R1A	16	Q13522
EIAPAAHLDPQLRTR	PC	276	P11498
ADLLQPERPLEARHA	TSC2	86	P49815
ALEDLVQTLRPHPAE	UBXN11	106	Q5T124
LPPEARIEASLQHEI	MYO5A	1391	Q9Y4I1
HVQDPNDRRLRPIYD	NAA25	6	Q14CX7